| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915838 | Nuclear Medicine and Biology | 2016 | 9 Pages |
Abstract
Although further studies are necessary, these data suggest that [11C]-4 may represent a good lead compound for the development of novel selective and potent A2B AR radiotracers, and a new option for the clinical investigation of several pathophysiological processes and chronic diseases.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Debora Petroni, Chiara Giacomelli, Sabrina Taliani, Elisabetta Barresi, Marco Robello, Simona Daniele, Antonietta Bartoli, Silvia Burchielli, Silvia Pardini, Piero A. Salvadori, Federico Da Settimo, Claudia Martini, Maria Letizia Trincavelli,